Interleukin-1 receptor-associated kinase 1 (IRAK1); SNP rs2239673; SNP rs763737; SNP rs3027907; SNP rs5945174; SNP rs7061789 BriefCommunication Pages: 567 - 567
Mammalian target of rapamycin (mTOR; FRAP; RAFT1); protein kinase B (PKB; Akt); tribbles homolog 3 (TRIB3; TRB3) BriefCommunication Pages: 569 - 569
Basic helix-loop-helix family, member e41 (BHLHE41; SHARP-1); cyclin G2 (CCNG2) BriefCommunication Pages: 570 - 570
Granulocyte macrophage colony-stimulating factor (CSF2; GM-CSF); VEGF; prokineticin 2 (PROK2; Bv8) BriefCommunication Pages: 572 - 572
Actin-related protein 2/3 complex, subunit 2 (ARPC2); fibronectin 1 (FN1); osteopontin (OPN; SPP1); regulator of G-protein signaling 1 (RGS1); wingless-type MMTV integration site family member 2 (WNT2) BriefCommunication Pages: 574 - 574
Major histocompatibility complex class II DP α1 (HLA-DPA1); HLA-DPB1 BriefCommunication Pages: 581 - 581
Tat protein; interferon-γ (IFN-γ); signal transducer and activator of transcription 1 (STAT1); suppressor of cytokine signaling 2 (SOCS2) BriefCommunication Pages: 582 - 582
Glucocorticoid receptor (NR3C1; GCCR); peroxisome proliferator–activated receptor-α (PPARA; PPARα) BriefCommunication Pages: 586 - 586
Purinergic receptor P2X ligand-gated ion channel 7 (P2RX7; P2X7 receptor); sphingomyelin phosphodiesterase 1, acid lysosomal (SMPD1; acid sphingomyelinase) BriefCommunication Pages: 587 - 587
Component 3a receptor 1 (C3AR1; C3AR); transforming growth factor-β receptor II (TGFBR2); growth arrest–specific 7 (GAS7); glutathione peroxidase 3 plasma (GPX3); zinc finger protein 90 homolog (ZFP90); NAPD-dependent malic enzyme (ME1); β-lactamase (LACTB); lipoprotein lipase (LPL) BriefCommunication Pages: 588 - 588
Protein kinase B (PKB; Akt); thioesterase superfamily member 4 (THEM4; CTMP) BriefCommunication Pages: 595 - 595
High throughput screening using activity-based protein profiling (ABPP) BriefCommunication Pages: 598 - 598
Cell-specific sulfonated gallium(III) corrole–based cytotoxic agents BriefCommunication Pages: 599 - 599
Inflammation-dependent, cationic liposome–mediated blood-brain barrier (BBB) targeting BriefCommunication Pages: 600 - 600
